252 related articles for article (PubMed ID: 23820854)
21. The Bromodomain Inhibitor
Siegenthaler B; Ghayor C; Gjoksi-Cosandey B; Ruangsawasdi N; Weber FE
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366476
[TBL] [Abstract][Full Text] [Related]
22. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro.
Jäger A; Götz W; Lossdörfer S; Rath-Deschner B
J Periodontal Res; 2010 Apr; 45(2):246-54. PubMed ID: 19778325
[TBL] [Abstract][Full Text] [Related]
23. [Biological function of bone cells on the PTH-driven anabolic effect].
Hasegawa T; Hongo H; Sasaki M; Yamada T; Amizuka N
Clin Calcium; 2012 Mar; 22(3):373-9. PubMed ID: 22370304
[TBL] [Abstract][Full Text] [Related]
24. Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia.
Chan WCW; Tsang KY; Cheng YW; Ng VCW; Chik H; Tan ZJ; Boot-Handford R; Boyde A; Cheung KMC; Cheah KSE; Chan D
Hum Mol Genet; 2017 Dec; 26(23):4572-4587. PubMed ID: 28973168
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.
Bellido T
J Musculoskelet Neuronal Interact; 2006; 6(4):358-9. PubMed ID: 17185824
[No Abstract] [Full Text] [Related]
26. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice.
Liu W; Wang Z; Yang J; Wang Y; Li K; Huang B; Yan B; Wang T; Li M; Zou Z; Yang J; Xiao G; Cui ZK; Liu A; Bai X
Open Biol; 2019 May; 9(5):180262. PubMed ID: 31088250
[TBL] [Abstract][Full Text] [Related]
27. Control of osteogenesis by the canonical Wnt and BMP pathways in vivo: cooperation and antagonism between the canonical Wnt and BMP pathways as cells differentiate from osteochondroprogenitors to osteoblasts and osteocytes.
Marcellini S; Henriquez JP; Bertin A
Bioessays; 2012 Nov; 34(11):953-62. PubMed ID: 22930599
[TBL] [Abstract][Full Text] [Related]
28. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck.
Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J
Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552
[TBL] [Abstract][Full Text] [Related]
29. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.
Gaudio A; Pennisi P; Bratengeier C; Torrisi V; Lindner B; Mangiafico RA; Pulvirenti I; Hawa G; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2010 May; 95(5):2248-53. PubMed ID: 20305005
[TBL] [Abstract][Full Text] [Related]
30. NMR structure of the Wnt modulator protein Sclerostin.
Weidauer SE; Schmieder P; Beerbaum M; Schmitz W; Oschkinat H; Mueller TD
Biochem Biophys Res Commun; 2009 Feb; 380(1):160-5. PubMed ID: 19166819
[TBL] [Abstract][Full Text] [Related]
31. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
Rossini M; Gatti D; Adami S
Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
[TBL] [Abstract][Full Text] [Related]
32. Paradoxical response to mechanical unloading in bone loss, microarchitecture, and bone turnover markers.
Sun X; Yang K; Wang C; Cao S; Merritt M; Hu Y; Xu X
Int J Med Sci; 2015; 12(3):270-9. PubMed ID: 25798053
[TBL] [Abstract][Full Text] [Related]
33. Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size.
Kogawa M; Khalid KA; Wijenayaka AR; Ormsby RT; Evdokiou A; Anderson PH; Findlay DM; Atkins GJ
Am J Physiol Cell Physiol; 2018 Jan; 314(1):C53-C61. PubMed ID: 28978523
[TBL] [Abstract][Full Text] [Related]
34. [Bone and Nutrition. Sclerostin and bone metabolism].
Tatsumi S; Nagamoto K; Ogata M; Miyamoto K
Clin Calcium; 2015 Jul; 25(7):1043-7. PubMed ID: 26119318
[TBL] [Abstract][Full Text] [Related]
35. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
[TBL] [Abstract][Full Text] [Related]
36. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways.
Krause C; Korchynskyi O; de Rooij K; Weidauer SE; de Gorter DJ; van Bezooijen RL; Hatsell S; Economides AN; Mueller TD; Löwik CW; ten Dijke P
J Biol Chem; 2010 Dec; 285(53):41614-26. PubMed ID: 20952383
[TBL] [Abstract][Full Text] [Related]
37. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats.
Nioi P; Taylor S; Hu R; Pacheco E; He YD; Hamadeh H; Paszty C; Pyrah I; Ominsky MS; Boyce RW
J Bone Miner Res; 2015 Aug; 30(8):1457-67. PubMed ID: 25678055
[TBL] [Abstract][Full Text] [Related]
39. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
[TBL] [Abstract][Full Text] [Related]
40. Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats.
Taylor S; Ominsky MS; Hu R; Pacheco E; He YD; Brown DL; Aguirre JI; Wronski TJ; Buntich S; Afshari CA; Pyrah I; Nioi P; Boyce RW
Bone; 2016 Mar; 84():148-159. PubMed ID: 26721737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
